Migraine Relief Tablet
NDC Package 43689-0017-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Migraine Relief (belladonna, bryonia (alba), chamomilla, cimicifuga racemosa, coffea cruda, glonoinum, iris versicolor, natrum muriaticum, passiflora incarnata, valeriana officinalis) tablets is adults and children 12 years and above:Dissolve 2 tablets under tongue 2 to 3 times daily or as directed by a physician.Children under 12 years: consult a physicianTake at least 10 minutes before or after eating or drinking. This formulation utilizes a tablet delivery system. Marketed by The Magni Company, this product is identified by NDC 43689-0017.

Identification & Billing

NDC Package Code
43689-0017-2
Package Description
1 BOTTLE in 1 CARTON / 90 TABLET in 1 BOTTLE (43689-0017-1)
Product Code
43689-0017
11-Digit Billing Format
43689001702

Clinical Specifications

Proprietary Name
Migraine Relief
Non-Proprietary Name
Belladonna, Bryonia (alba), Chamomilla, Cimicifuga Racemosa, Coffea Cruda, Glonoinum, Iris Versicolor, Natrum Muriaticum, Passiflora Incarnata, Valeriana Officinalis
Substance Name
Arabica Coffee Bean; Atropa Belladonna; Black Cohosh; Bryonia Alba Root; Iris Versicolor Root; Matricaria Chamomilla Whole; Nitroglycerin; Passiflora Incarnata Flowering Top; Sodium Chloride; Valerian
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Adults and children 12 years and above:Dissolve 2 tablets under tongue 2 to 3 times daily or as directed by a physician.Children under 12 years: consult a physicianTake at least 10 minutes before or after eating or drinking.

Regulatory & Marketing

Labeler Name
The Magni Company
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
07-17-2014
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 43689-0017-2 identifies a specific commercial package of 1 bottle in 1 carton / 90 tablet in 1 bottle (43689-0017-1) of Migraine Relief, a human over the counter drug labeled by The Magni Company. This tablet is formulated for oral use and contains arabica coffee bean; atropa belladonna; black cohosh; bryonia alba root; iris versicolor root; matricaria chamomilla whole; nitroglycerin; passiflora incarnata flowering top; sodium chloride; valerian as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by The Magni Company on July 17, 2014. The current certification is valid through December 31, 2027.

How is this The Magni Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 43689001702. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
43689-0017-2
11-Digit CMS (5-4-2)
43689-0017-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.